DrugSupplement
Tributyrin clinical trials
- studies test it
- 13
- open now
- 8
- in phase 3
- 2
- first study started
- 1995
Keep track of what changes. Save the tributyrin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
12 studies that test it; most in 2026 (5); 1 more planned to start later
| Year | Studies |
|---|---|
| 1995 | 1 |
| 2013 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 5
- Phase 2
- 3
- Phase 3
- 2
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 13
Prabesh Kanel (2) · University of Maryland, Baltimore (1) · Glostrup University Hospital, Copenhagen (1) · George Washington University (1) · Ain Shams University (1) · Universidad de Almeria (1) · University of British Columbia (1) · Sixth Affiliated Hospital, Sun Yat-sen University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses tributyrin is read from its arms, and is right about nine times in ten.
Testing it · 13
- Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual TrialRecruitingPhase 1/2Prabesh KanelNCT07863180Written as Tributyrin
- A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)Not yet recruitingPhase 1/2George Washington UniversityNCT06792500Written as Glycerol Tributyrate
- A Prospective, Single-Arm Clinical Study of a Dietary Supplement for the Prevention of Acute Radiation-Induced Rectal Injury During Neoadjuvant Chemoradiotherapy for Rectal CancerRecruitingNot applicableSixth Affiliated Hospital, Sun Yat-sen UniversityNCT07802002Written as Tributyrin
- Effect of Tributyrin Supplementation on Glycemic Control, Inflammation, and Cardiovascular Risk in Patients With Type 2 DiabetesNot yet recruitingPhase 3Ain Shams UniversityNCT07503548Written as tributyrin
- The Metabolic Effects of Oral Tributyrin AdministrationRecruitingNot applicableUniversity of AarhusNCT07463495Written as tributyrin
- Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-BrainNot yet recruitingPhase 3Universidad de AlmeriaNCT06797817Written as tributyrin
- Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive ImpairmentsRecruitingPhase 1/2Prabesh KanelNCT07154511Written as Tributyrin
- ButOx Human Trial: An Open Label Prospective Cohort Study to Investigate the Effect of Tributyrin (Butyrate Precursor Molecule) Supplementation on Markers of Calcium Oxalate NephrolithiasisNot yet recruitingNot applicableUniversity of British ColumbiaNCT07004257Written as tributyrin
- Tributyrin: Time Course & Efficacy to Improve Health & PerformanceTerminatedNot applicableFlorida State UniversityNCT06501898Written as CoreBiome
- Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin SupplementationTerminatedPhase 1Nicolaas Bohnen, MD, PhDNCT05446168Written as tributyrin
- Tributyrin to Promote Gut Health Among Children Undergoing Hematopoietic Cell TransplantationWithdrawnEarly Phase 1Duke UniversityNCT05951153Written as Tributyrin
- Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid TumorsCompletedPhase 1University of Maryland, BaltimoreNCT00002677Written as tributyrin
- Fat-induced Release of GLP-1 in HumansCompletedNot applicableGlostrup University Hospital, CopenhagenNCT02264951Written as Tributyrin
As the comparator · 1 — what is tested is compared with tributyrin
Codes
What other systems call tributyrin · ClinicalTrials.gg INT002350
- MeSH (NLM) C005830tributyrinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) S05LZ624MFTRIBUTYRINConfirmed FDA, NLM, Wikidata
- Wikidata Q4116129tributyrinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1260TributyrinOne source FDA
- DrugBank DB12709One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C005830 | tributyrin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | S05LZ624MF | TRIBUTYRIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q4116129 | tributyrin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1260 | Tributyrin | One source FDA |
| DrugBank | DB12709 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.